Welcome to NanoSphere
The #1 nanomedicine science-translation platformโbridging lab to market fast.
The #1 nanomedicine
science-translation
platformโbridging lab to market fast.
We decode LNPs, RNA, delivery tech, ADCs & personalized medicine, so innovators can act, build, and scale.
๐ฃ Monthly updates on lipid nanoparticles (LNPs), nucleic acids, proteins, peptides, antibodies, ADCs
๐ฃMonthly newsletter covering nanomedicine across academia, industry, regulatory, business, and clinical sectors
From deep science to bold strategy, NanoSphere bridges the gap between the lab bench and the boardroom.
๐ช๐ฒ ๐ต๐ฒ๐น๐ฝ ๐ถ๐ป๐ป๐ผ๐๐ฎ๐๐ผ๐ฟ๐ ๐บ๐ผ๐๐ฒ ๐ณ๐ฎ๐๐๐ฒ๐ฟโ๐ฏ๐ ๐บ๐ฎ๐ธ๐ถ๐ป๐ด ๐๐ฒ๐ป๐๐ฒ ๐ผ๐ณ ๐๐ต๐ฒ ๐๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ ๐ฏ๐ฒ๐ต๐ถ๐ป๐ฑ ๐๐ต๐ฒ ๐ป๐ฒ๐ ๐ ๐๐ฎ๐๐ฒ ๐ผ๐ณ ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ถ๐ป๐ฒ.
๐ช๐ต๐ฎ๐ ๐๐ฒ ๐ฑ๐ผ:
We are your go-to hub for expert insights, real-world applications, and the latest breakthroughs in nano-carriers and nanomedicine. We provide you with:
๐ช๐ต๐ ๐๐ฒโ๐ฟ๐ฒ ๐ฑ๐ถ๐ณ๐ณ๐ฒ๐ฟ๐ฒ๐ป๐:
Weโre built by scientists whoโve been in the trenchesโand backed by operators who know how to launch. From regulatory know-how to commercial strategy, we connect the dots others miss.
๐๐ฎ๐๐ฒ๐ฑ ๐ถ๐ป ๐ฆ๐๐ถ๐๐๐ฒ๐ฟ๐น๐ฎ๐ป๐ฑ. ๐๐ฎ๐ฐ๐ธ๐ฒ๐ฑ ๐ฏ๐ ๐๐ข๐ก๐๐๐ง. ๐ช๐ถ๐ฟ๐ฒ๐ฑ ๐ถ๐ป๐๐ผ ๐๐ต๐ฒ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ถ๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป ๐ฒ๐ฐ๐ผ๐๐๐๐๐ฒ๐บ.
Follow us for curated content, expert takes, and fast access to whatโs next in nanomedicine.
๐ช๐ต๐ฒ๐๐ต๐ฒ๐ฟ ๐๐ผ๐โ๐ฟ๐ฒ ๐ฎ ๐๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐๐, ๐ณ๐ผ๐๐ป๐ฑ๐ฒ๐ฟ, ๐ถ๐ป๐๐ฒ๐๐๐ผ๐ฟ, ๐ผ๐ฟ ๐ฝ๐ผ๐น๐ถ๐ฐ๐๐บ๐ฎ๐ธ๐ฒ๐ฟ, ๐๐ฒ ๐ด๐ถ๐๐ฒ ๐๐ผ๐ ๐๐ต๐ฒ ๐ถ๐ป๐๐ถ๐ด๐ต๐๐ ๐๐ผ ๐ฎ๐ฐ๐, ๐ฏ๐๐ถ๐น๐ฑ, ๐ฎ๐ป๐ฑ ๐๐ฐ๐ฎ๐น๐ฒ.
I really appreciate the efforts of Nanosphere in connecting researchers in the field for open collaboration and knowledge sharing.
โ Natalia Markova, PhD, Head of Science Pharma, Malvern Panalytical
Thank you to the NanoSphere team for the thoughtful interview and for ๐ฝ๐ฟ๐ผ๐๐ถ๐ฑ๐ถ๐ป๐ด ๐๐ต๐ฒ ๐ณ๐ถ๐ฒ๐น๐ฑ ๐๐ถ๐๐ต ๐ฎ ๐ต๐๐ฏ ๐ผ๐ณ ๐ฐ๐ผ๐ป๐๐ฒ๐ฟ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ต๐ฎ๐ ๐ถ๐ ๐ฑ๐ถ๐ณ๐ณ๐ถ๐ฐ๐๐น๐ ๐๐ผ ๐ณ๐ถ๐ป๐ฑ ๐ผ๐๐๐๐ถ๐ฑ๐ฒ ๐ผ๐ณ ๐ฐ๐ผ๐ป๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ๐. A clear labor of love!
โ Sean Bedingfieldm PhD, Senior Advisor at Eli Lilly and Company's Genetic Medicine division
Thanks for the shout-out NanoSphere! I just learned about NanoSphere from this post, and now I see ๐ถ๐ ๐ถ๐ ๐๐ต๐ฒ ๐ฝ๐น๐ฎ๐ฐ๐ฒ ๐๐ผ ๐ด๐ผ ๐ณ๐ผ๐ฟ ๐ฎ๐น๐น ๐๐ต๐ถ๐ป๐ด๐ ๐ป๐ฎ๐ป๐ผ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ถ๐ป๐ฒ. Super cool resource for the community!
โ Jake Brenner, Assistant Professor at the University of Pennsylvania
About Nanomedicine from a KOL angle
โThis is an exciting time for nanomedicine where we need to put more effort into clinical translation and less effort into all-singing-all-dancing formulations that may be academically interesting but a regulatory nightmare.โ
โ Olivia Merkel
โFor nanomedicine scientists, this is an exciting era. Nucleic acid payloads (especially longer nucleic acid modalities such as mRNA or circRNA) require an efficient delivery technology - and it is up to us, as a community, to develop innovative solutions that enable safe and effective delivery to the target siteโ
โ Dominik Witzigmann
โIt really is remarkable how much the field has evolved over the past 10 years and what an impact genetic medicines will have in the future. Delivery scientists canโt do this alone though; cross-disciplinary collaborations between academics and industry are key to unlocking the potential of the field. Iโm confident that the nanomedicine field will play a vital role in enabling the therapies of tomorrow, we just need to pull in the best and the brightest to realize that vision.โ
โ Luis Brito
โIn my view, the immediate future of nanomedicine lies in precision therapies, cell therapies, and the formulation of biological drugs, enabling them to overcome biological barriers and effectively reach their intended targets. This is already establishing a new paradigm in the way we approach disease treatment. Advanced therapies and vaccines are ushering in a new era in medicine.โ
โ Maria Jose Alonso
โNanomedicine is here to stay, having proven its contribution to offer new opportunities and solutions for diagnosing, treating, and preventing diseases that were untreatable, and even expanding to individualized therapeutic treatments. To ensure the future of nanomedicine, we need to work together as scientific community to overcome certain challenges and embrace our combined strengths.โ
โ Eleni Samaridou
โI enjoy working in the field of nanomedicine because it brings together insights from a wide range of scientific disciplines. While the field itself is not new and builds on decades of research, the recent surge in interest and investmentโespecially in technologies LNPsโcan sometimes feel overwhelming. Still, it's important not to underestimate how much there is yet to learn about these complex systems.โ
โ Rein Verbeke
NanoSphere ChatGPT
Explore this prompt to quickly get acquainted with the fascinating world of nanomedicine